Fundraising FoxEgalet
Wayne, US · Delaware corporation · 2 known investors
Find your way into Egalet
Sign up to see every warm intro you have to Egalet
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Egalet team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Egalet develops medicines for people living with moderate to severe pain, including approved and licensed pain products. It operates in the pharmaceutical industry focused on pain treatment.
Founders & leadership
BA
BARBARA A. CARLINSENIOR VICE PRESIDENT AND CHIEF ACCOUNTING OFFICER
RS
ROBERT S. RADIECHIEF EXECUTIVE OFFICER
MS
MARK STROBECKEXECUTIVE VICE PRESIDENT AND CHIEF OPERATING OFFICER
MT
MEGAN TIMMINSSENIOR VICE PRESIDENT AND GENERAL COUNSEL
PM
PATRICK M. SHEASENIOR VICE PRESIDENT AND CHIEF COMMERCIAL OFFICER
JM
Jeffrey M. DaynoChief Medical Officer
KL
Karsten LindhardtSenior Vice President
DM
Deanne MelloyChief Commercial Officer
SM
Stan MusialChief Financial Officer
AH
ANDREA HESLIN SMILEYNamed on SEC filing
JM
JOSEPH MCINNISNamed on SEC filing
MP
MATTHEW PAULSNamed on SEC filing
Investors · 2
Sunstone Capitallisted by Sunstone CapitalFrederiksberg
How we know: Sunstone Capital's portfolio page · Not right? Tell us
Atlas VenturereportedCambridge · $500K – $1M
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$42.2M disclosed across 1 round · 2019
▶$42.2MraisedFeb 2019 · 1 investors · PharmaceuticalsRule 506(b)
▶$42.2MraisedFeb 2019 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- ANDREA HESLIN SMILEYDirector
- JOSEPH MCINNISDirector
- BARBARA A. CARLINExecutive Officer
- MATTHEW PAULSDirector
- TODD HOLMESDirector
- ROBERT S. RADIEExecutive Officer, Director
- TIMOTHY P. WALBERTDirector
- MARK STROBECKExecutive Officer
- MEGAN TIMMINSExecutive Officer
- LUKE DUSTERDirector
- PATRICK M. SHEAExecutive Officer
- Offering amount
- $42.2M
- Amount sold
- $42.2M
- First sale
- Jan 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 2
MedscapeMedscape is an online platform providing medical news, clinical information, and continuing education resources to physicians and healthcare professionals globally. The platform offers CME courses, drug and disease information, and patient education across multiple specialties.
PrescriberPointPrescriberPoint operates an AI-enabled medication access platform that helps clinicians get patients onto prescribed therapies by providing prescribing support, coverage and cost-savings lookups in one place. It serves healthcare providers in the medication access and prescribing space.
Companies working in the same space as Egalet.
In the news
Frequently asked questions
- What does Egalet do?
- Egalet develops medicines for people living with moderate to severe pain, including approved and licensed pain products. It operates in the pharmaceutical industry focused on pain treatment.
- Who are Egalet's investors?
- Egalet's investors include Sunstone Capital, Atlas Venture.
- How much funding has Egalet raised?
- Egalet has disclosed $42.2M raised across 1 round.
- Where is Egalet headquartered?
- Egalet is headquartered in Wayne, US.